Skip Navigation

Health: Drug development

Opinions

Here is a list of the latest articles

Africa Analysis: Continent must back TB research drive

International bodies are offering true research opportunities, but African funding is needed to prepare the ground, writes Linda Nordling.

4 April 2013 | EN | FR

Vaccine development

Failing vaccine strategies need to be revamped

New approaches are needed to reverse the trend of disappointing vaccines against HIV/AIDS, tuberculosis and malaria, argues biotech expert Thomas Egwang.

5 March 2013 | EN | FR

Fármacos

New R&D model to promote access to drugs

More affordable and effective treatments will be the result of a binding convention on R&D in health, according to an expert.

Source: Boletín de la OMS

16 November 2012 | ES

Farmer holds rice seeds, Ghana

Responsible science is vital for development

S&T advances should safeguard health, equity and the rights of vulnerable populations, says rural development professional Bhavani R. V.

26 September 2012 | EN | ES | FR | 中文

Biomed Analysis: India mustn't bow to patent pressure

The latest round of challenges to India's drug patent laws is a fight that must be won for the world's poor, says Priya Shetty.

19 September 2012 | EN | ES

Farmer in Potato Park, Peru

Making the Nagoya Protocol work at the community level

Two safeguards for communities' rights to resources can help implement the Nagoya Protocol, argues biodiversity specialist Krystyna Swiderska.

3 July 2012 | EN | ES

Biomed Analysis: A cautious welcome for online trials

Online clinical trials hold promise for research but scientists should think hard before using them in poorer countries, says Priya Shetty.

19 June 2012 | EN

Global treaty would improve access to health

A binding international convention would facilitate a move towards more equitable access to R&D in health, according to Suerie Moon and colleagues.

Source: PLoS Medicine

23 May 2012 | EN | ES

Nurse holding antiretroviral pills, Zimbabwe

Use new funding models to get drugs to world's poor

Trade deals are threatening generic drugs — we need new ways to incentivise affordable drug development, says health expert Daniele Dionisio.

5 April 2012 | EN | ES

Biomed Analysis: Why Africa must make its own drugs

There is a pressing need for Africa to bolster its pharmaceuticals industry, and that requires the right policy framework, argues Priya Shetty.

22 March 2012 | EN

Girl with bed net, Ethiopia

Taking life-saving innovations from lab to village

Improving health for the poor depends on nurturing local innovations — and learning how to deliver them, argue Abdallah Daar and Peter Singer.

15 March 2012 | EN | FR

Research needed to tackle neglected disease uncertainties

The revised malaria death toll suggests a need for research into uncertainties in controlling neglected tropical diseases, says Mark Booth.

Source: New Statesman

7 February 2012 | EN

Biomed Analysis: Learning from India's polio success

India's carefully targeted strategy against polio holds lessons for other countries, and for other diseases, argues Priya Shetty.

31 January 2012 | EN | FR

Women weighing Chinese medicine

Redesign trials to integrate Asian, Western medicine

New clinical trial designs can work for testing both Western and traditional medicines, argue Liang Liu and colleagues.

Source: Nature

4 January 2012 | EN

Biomed Analysis: Target sex differences in research

Diseases, and drugs used to treat them, behave differently in men and women. Drug development needs to account for this, says Priya Shetty.

18 August 2011 | EN

Biomed Analysis: No single path to HIV prevention

Excitement about new drug treatment for HIV prevention does not mean we should lose sight of other methods, cautions Priya Shetty.

22 July 2011 | EN

Quechua weavers, Peru

Genomics must reflect racial and ethnic diversity

Developing world scientists should be empowered to do their own medical genomics research, say Carlos D. Bustamante and colleagues.

Source: Nature

20 July 2011 | EN | ES

Medicines in Bangkok, Thailand

Free-trade provisions will damage access to medicines

Impact studies warn that TRIPS-Plus provisions can lead to higher prices and reduced access to medicines, say Nusaraporn Kessomboon and colleagues.

3 June 2011 | EN | ES

Scientist at the UVRI-IAVI HIV Vaccine Program, Uganda

How health R&D can boost development

Health research partnerships do more for development than just tackling illness, argues AIDS vaccine R&D leader Seth Berkley.

3 May 2011 | EN

Pharmacy shelf, Guinea

'Counterfeit' confusion diverts action from drug quality

Both fake and substandard medicines threaten public health, and efforts to tackle them must put the focus on quality, says Leena Menghaney.

30 March 2011 | EN | ES | FR | 中文